Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Portrait de Jeffrey S. Aronin
Alter : 52
Vermögen : 1 795 465 USD
Größte Unternehmen : Discover Financial Services - Harmony Biosciences Holdings, Inc.
Übersicht 
Founder of 7 different companies, which include: OVATION Pharmaceuticals, Inc., Paragon Biosciences LLC and Emalex Biosciences, Inc. Jeffrey S. Aronin is an entrepreneur and businessperson who has been at the head of 10 different companies and occupies the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Co-Chairman of MATTER Chicago (which he founded), Non-Executive Chairman for Harmony Biosciences Holdings, Inc., Chairman & Chief Executive Officer of Paragon Biosciences LLC (which he founded in 2010), Chairman & Chief Executive Officer for Emalex Biosciences, Inc. (which he founded), Chairman for Castle Creek Biosciences, Inc. (which he founded in 2018) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Mr. Aronin is also on the board of 14 other companies.

In the past Mr. Aronin held the position of Chairman & Chief Executive Officer for Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer at Enterprise Technologies, Inc., President & Chief Executive Officer of OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer at Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

He received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.


Aktuelle Stellungen und Verantwortungsbereiche Jeffrey S. Aronin 
NameTitel Seit
Discover Financial Services
(Banken)
Independent Director 2008
Harmony Biosciences Holdings, Inc.
(Pharmazeutika)
Non-Executive Chairman 2017
Paragon Pharmaceuticals Capital LLC Chairman & Chief Executive Officer 2010
Paragon Biosciences LLC Chairman & Chief Executive Officer 2010
Emalex Biosciences, Inc. Chairman & Chief Executive Officer -
MATTER Chicago Co-Chairman -
Castle Creek Biosciences, Inc. Chairman 2018
The University of Chicago Medical Center Director -
The Aspen Institute, Inc. Director -
The Commercial Club of Chicago Director -
Pharmaceutical Research & Manufacturers of America Director 2010
Ravinia Festival Association Trustee -
Castle Creek Pharmaceuticals LLC Director 2015
Harmony Biosciences LLC Director -
Paragon Biosciences Emalex Capital, Inc. Director -
Paragon Biosciences Skyline Capital LLC Director & Manager -
Castle Creek Pharmaceutical Holdings, Inc. Director -
Paragon Biosciences Qlarity Capital, Inc. Director -
Qlarity Imaging LLC Director -
Skyline Biosciences LLC Director -
CIRC Biosciences, Inc. Director -


Anteile an Jeffrey S. Aronin 
NameAktien%Wert
Discover Financial Services (DFS)
(Banken)
14 0030,0047%1 795 465 USD


Jeffrey S. Aronin: Persönliches Netzwerk 
Meistgelesene News 
22.09.WILLIAM ACKMAN : Ackmans Pershing-Square-Fonds steigt, während Universal beim Börsendebüt in die Höhe schießt
MR
24.09.CATHIE WOOD : Chinesisches Durchgreifen gegen Bitcoin ein weiterer Schlag für Cathie Woods ARK ETF
MR
15.09.BRAD SMITH : Microsoft kündigt Aktienrückkauf im Wert von bis zu 60 Mrd. Dollar an und erhöht die Dividende
MR
14.09.ROLF BUCH : Übernehmen Deutsche Wohnen 'auf jeden Fall'
DP
24.09.ELON MUSK : Tesla-Chef Musk setzt bei Behebung der Chipkrise auf neue Fabriken
RE
17.09.ROLF BUCH : Immobilienriesen verkaufen 14.750 Wohnungen an öffentliche Hand
RE
17.09.ELON MUSK : Tesla-Chef Musk kommt zum Tag der offenen Tür nach Deutschland
DP
17.09.CHRISTIAN SEWING : Sewing entschuldigt sich für scharfe Kritik in Studie seines Hauses
DP
14.09.STEPHEN SCHERR : Goldman Sachs ernennt Coleman zum neuen CFO und löst damit Scherr ab
MR
21.09.FRANK APPEL : Für Konzernchef Appel ist Vorsicht besser als Nachsicht
DP
Weitere Nachrichten


© 2021 People and Ownership :   
Jeffrey S. Aronin : Verbindungen